Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T60654 | KDM4C-IN-1
KDM4C抑制剂1
|
52348-60-4 | 99.33% |
|
KDM4C-IN-1 是一种具有选择性和高效性的KDM4C 抑制剂(IC50:8 nM),具有潜在的抗癌活性。KDM4C-IN-1 抑制 HepG2 和 A549 细胞的生长,可用于研究白血病。 | ||||
T24131 | HDAC3-IN-T247
HDAC3抑制剂T247
|
1451042-18-4 | 98.94% |
|
HDAC3-IN-T247 (HDAC3 inhibitor T247) 是一种具有选择性和有效性的组蛋白去乙酰化酶 3(HDAC3) 抑制剂,具有抗癌和抗病毒活性。HDAC3-IN-T247 以剂量依赖的方式诱导人结肠癌 HCT116 细胞中 NF-κB 乙酰化。HDAC3-IN-T247 抑制癌细胞增殖。 | ||||
T39989 | JQKD82
化合物JQKD82
|
2410512-38-6 | 100.00% |
|
JQKD82 是 KDM5 的选择性抑制剂,可增加 H3K4me3。 JQKD82可用于治疗多发性骨髓瘤的研究。 | ||||
T35338 | CP2
CP2
|
98% |
|
|
CP2是一种环肽,能够抑制JmjC histone demethylases KDM4,对KDM4A 和KDM4C 的IC50分别为42 nM 和29 nM。 | ||||
T13057 | T-448
化合物 T13057
|
1597426-53-3 | 98% |
|
T-448 is a specific, orally active and irreversible lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) inhibitor(IC50 of 22 nM). | ||||
T78577 | NCD38 TFA
化合物 NCD38 TFA
|
98% |
|
|
NCD38 TFA为LSD1的选择性抑制剂,具有高亲和力和特异性。 | ||||
T78888 | LSD1-UM-109
化合物 LSD1-UM-109
|
2252446-26-5 | 98% |
|
LSD1-UM-109为一强效可逆LSD1抑制剂,其IC50为3.1 nM。在MV4;11急性白血病细胞系中,该化合物抑制细胞生长,IC50值达0.6 nM,在H1417小细胞肺癌细胞系中,IC50值为1.1 nM。 | ||||
T82254 | GSK-LSD1
化合物 GSK-LSD1
|
1431368-48-7 | 98% |
|
GSK-LSD1是一种LSD1抑制剂,能够降低肥胖小鼠模型的摄食量和体重,同时提升胰岛素敏感性与血糖控制。此外,GSK-LSD1对NAFLD也有改善作用,并能抑制COVID-19患者PBMC中SARS-CoV-2诱导的细胞因子释放。GSK-LSD1对抑制癌症的生长与转移也显示出潜在效果。 | ||||
T12701 | (rel)-Tranylcypromine D5 hydrochloride
化合物 T12701
|
107077-98-5 | 98% |
|
(rel)-Tranylcypromine D5 hydrochloride is a deuterium labeled (rel)-Tranylcypromine hydrochloride. (rel)-Tranylcypromine hydrochloride is an irreversible, nonsel... | ||||
T22299 | CPI-455 HCl
化合物CPI-455 HCl
|
2095432-28-1 | 98% |
|
CPI-455 is a specific KDM5 inhibitor with IC50 value of 10 ± 1 nM for full-length KDM5A in enzymatic assays, elevating global levels of H3K4 trimethylation (H3K... | ||||
T17278 | YUKA1
化合物 T17278
|
708991-09-7 | 98% |
|
YUKA1 is a potent and cell-permeable Lysine demethylase 5A inhibitor (IC50: 2.66 μM) and less active on KDM5C (IC50, 7.12 μM). YUKA1 is inactive on KDM5B, KDM6A,... | ||||
T11755 | KF 13218
化合物 T11755
|
127654-03-9 | 98% |
|
KF 13218 is a selective, potent and long lasting thromboxane B2 (TXB2) synthase inhibitor with an IC50 value of 5.3±1.3 nM. | ||||
T3677 | GSK2879552
化合物GSK2879552
|
1401966-69-5 | 98% |
|
GSK2879552 是一种选择性的、可口服的、不可逆的、基于机制的赖氨酸特异性去甲基化酶 1 (LSD1)/辅阻遏物灭活剂,具有潜在的抗肿瘤活性。 | ||||
T74855 | LSD1-IN-25
化合物 LSD1-IN-25
|
2911585-60-7 | 98% |
|
LSD1-IN-25(Compound 9j)是一种高效、选择性及口服活性的LSD1抑制剂,具有46 nM的IC50(Ki值为30.3 nM),并能够诱导癌细胞的凋亡(apoptosis)。 | ||||
T13052 | S2101
化合物 T13052
|
1239262-36-2 | 98% |
|
S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact/Ki of 4560 M/s). | ||||
T11475 | GSK-J1 lithium salt
化合物 T11475
|
2309668-29-7 | 98% |
|
GSK-J1 lithium salt 是一种有效的 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的抑制剂,对 KDM6B 的 IC50值为 60 nM。 | ||||
T13056 | T-448 free base
化合物 T13056
|
1597426-52-2 | 98% |
|
T-448 free base is a specific, orally active and irreversible lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) inhibitor(IC50 of 22 nM). | ||||
T16700 | QC6352
化合物 T16700
|
1851373-36-8 | 98% |
|
QC6352 is a selective and effective KDM4C inhibitor (IC50: 35 nM). | ||||
T11881 | LSD1-IN-6
化合物 T11881
|
2035912-43-5 | 98% |
|
LSD1-IN-6 increases dimethylated Lys4 of histone H3, shows no effect on expression of LSD1. LSD1-IN-6 is a potent and reversible inhibitor of lysine-specific dem... | ||||
T11503 | GSK 690 Hydrochloride
化合物 T11503
|
2436760-79-9 | 98% |
|
GSK 690 (Hydrochloride) 是一种可逆的赖氨酸特异性去甲基化酶1 (LSD1)抑制剂,Kd 值为 9 nM,IC50值为 37 nM。 |